Hematologic Malignancies
Showing NaN - NaN of 13
Hematologic Malignancies Trial in Chicago, New York (device, drug, radiation)
Recruiting
- Hematologic Malignancies
- CliniMACS® CD34 Reagent System
- +7 more
-
Chicago, Illinois
- +1 more
Sep 20, 2022
Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)
Terminated
- Hematologic Malignancies
- Itacitinib
- Calcineurin inhibitor
-
Aurora, Colorado
- +16 more
Apr 29, 2022
Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)
Recruiting
- Hematologic Malignancies
- Busulfan 3.2 mg/kg/day
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 14, 2022
Hematologic Malignancies Trial in United States (ProHema-CB, Untreated CB)
Terminated
- Hematologic Malignancies
- ProHema-CB
- Untreated CB
-
Duarte, California
- +10 more
Nov 26, 2021
Hematologic Malignancies Trial in United States (IPI-145 (duvelisib))
Terminated
- Hematologic Malignancies
- IPI-145 (duvelisib)
-
New York, New York
- +3 more
Mar 15, 2021
Cord Blood Stem Cell Transplantation, Hematologic Malignancies Trial in United States (Cord blood transplantation)
Completed
- Cord Blood Stem Cell Transplantation
- Hematologic Malignancies
- Cord blood transplantation
-
Duarte, California
- +9 more
Mar 7, 2014
Streptococcal Sepsis, Hematologic Malignancies Trial in New York (Empirical Vancomycin, Prophylactic Vancomycin)
Completed
- Streptococcal Sepsis
- Hematologic Malignancies
- Empirical Vancomycin
- Prophylactic Vancomycin
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Sep 7, 2006